Nos P - Search Results

1

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry.

Calafat M, Mañosa M, Mesonero F, Guardiola J, Mínguez M, Nos P, Vera I, Taxonera C, Iglesias E, Ricart E, Gisbert JP, Calvet X, García-López S, Monfort D, Pérez Calle JL, Riestra S, Gomollón F, Garcia-Planella E, Bermejo F, Hernández V, Martín-Arranz MD, Gutiérrez A, Torres P, Cañete F, Domènech E; ENEIDA registry of GETECCU. Calafat M, et al. Among authors: nos p. J Crohns Colitis. 2020 Sep 16;14(9):1290-1298. doi: 10.1093/ecco-jcc/jjaa055. J Crohns Colitis. 2020. PMID: 32201893

2

Relationship between smoking and colonic involvement in inflammatory bowel disease.

Bustamante M, Nos P, Hoyos M, Hinojosa J, Molés JR, García-Herola A, Berenguer J. Bustamante M, et al. Among authors: nos p. Rev Esp Enferm Dig. 1998 Dec;90(12):833-40. Rev Esp Enferm Dig. 1998. PMID: 9973845 English, Spanish.

3

[Budesonide and inflammatory bowel disease].

Gomollón F, Hinojosa J, Nos P. Gomollón F, et al. Among authors: nos p. Gastroenterol Hepatol. 1999 Dec;22(10):525-32. Gastroenterol Hepatol. 1999. PMID: 10650668 Review. Spanish. No abstract available.

4

[Budesonide in inflammatory bowel disease: a meta-analysis].

Nos P, Hinojosa J, Gomollón F, Ponce J. Nos P, et al. Med Clin (Barc). 2001 Jan 20;116(2):47-53. doi: 10.1016/s0025-7753(01)71716-2. Med Clin (Barc). 2001. PMID: 11181269 Review. Spanish.

5

Adverse effects of azathioprine in the treatment of inflammatory bowel disease.

Martínez F, Nos P, Pastor M, Garrigues V, Ponce J. Martínez F, et al. Among authors: nos p. Rev Esp Enferm Dig. 2001 Dec;93(12):769-78. Rev Esp Enferm Dig. 2001. PMID: 11995359 English, Spanish.

6

6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.

Domènech E, Nos P, Papo M, López-San Román A, Garcia-Planella E, Gassull MA. Domènech E, et al. Among authors: nos p. Scand J Gastroenterol. 2005 Jan;40(1):52-5. doi: 10.1080/00365520410009492. Scand J Gastroenterol. 2005. PMID: 15841714

7

Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease.

Bastida G, Nos P, Aguas M, Beltrán B, Rubín A, Dasí F, Ponce J. Bastida G, et al. Among authors: nos p. Aliment Pharmacol Ther. 2005 Nov 1;22(9):775-82. doi: 10.1111/j.1365-2036.2005.02636.x. Aliment Pharmacol Ther. 2005. PMID: 16225485 Free article.

8

Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?

Domènech E, Hinojosa J, Nos P, Garcia-Planella E, Cabré E, Bernal I, Gassull MA. Domènech E, et al. Among authors: nos p. Aliment Pharmacol Ther. 2005 Dec;22(11-12):1107-13. doi: 10.1111/j.1365-2036.2005.02670.x. Aliment Pharmacol Ther. 2005. PMID: 16305724 Free article. Clinical Trial.

9

[Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease].

Cabriada JL, Doménech E, Gomollón F, González-Carro P, González-Lara V, Hinojosa J, Jiménez-López CE, Nos P, Obrador A, Panès J, Saro C, Varea V, Lafuente R, Guilera M. Cabriada JL, et al. Among authors: nos p. Gastroenterol Hepatol. 2006 Feb;29(2):85-92. doi: 10.1157/13083905. Gastroenterol Hepatol. 2006. PMID: 16448611 Spanish. No abstract available.

10

Crohn's disease: a review of current treatment with a focus on biologics.

Panés J, Gomollón F, Taxonera C, Hinojosa J, Clofent J, Nos P. Panés J, et al. Among authors: nos p. Drugs. 2007;67(17):2511-37. doi: 10.2165/00003495-200767170-00005. Drugs. 2007. PMID: 18034589 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page